• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在多样化人群中纳入既往乳腺钼靶检查结果的动态风险预测模型的验证

Validation of a Dynamic Risk Prediction Model Incorporating Prior Mammograms in a Diverse Population.

作者信息

Jiang Shu, Bennett Debbie L, Colditz Graham A

机构信息

Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine in St Louis, St Louis, Missouri.

Department of Radiology, Washington University School of Medicine in St Louis, St Louis, Missouri.

出版信息

JAMA Netw Open. 2025 Jun 2;8(6):e2512681. doi: 10.1001/jamanetworkopen.2025.12681.

DOI:10.1001/jamanetworkopen.2025.12681
PMID:40478575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12144620/
Abstract

IMPORTANCE

For breast cancer risk prediction to be clinically useful, it must be accurate and applicable to diverse groups of women across multiple settings.

OBJECTIVE

To examine whether a dynamic risk prediction model incorporating prior mammograms, previously validated in Black and White women, could predict future risk of breast cancer across a racially and ethnically diverse population in a population-based screening program.

DESIGN, SETTING, AND PARTICIPANTS: This prognostic study included women aged 40 to 74 years with 1 or more screening mammograms drawn from the British Columbia Breast Screening Program from January 1, 2013, to December 31, 2019, with follow-up via linkage to the British Columbia Cancer Registry through June 2023. This provincial, organized screening program offers screening mammography with full field digital mammography (FFDM) every 2 years. Data were analyzed from May to August 2024.

EXPOSURE

FFDM-based, artificial intelligence-generated mammogram risk score (MRS), including up to 4 years of prior mammograms.

MAIN OUTCOMES AND MEASURES

The primary outcomes were 5-year risk of breast cancer (measured with the area under the receiver operating characteristic curve [AUROC]) and absolute risk of breast cancer calibrated to the US Surveillance, Epidemiology, and End Results incidence rates.

RESULTS

Among 206 929 women (mean [SD] age, 56.1 [9.7] years; of 118 093 with data on race, there were 34 266 East Asian; 1946 Indigenous; 6116 South Asian; and 66 742 White women), there were 4168 pathology-confirmed incident breast cancers diagnosed through June 2023. Mean (SD) follow-up time was 5.3 (3.0) years. Using up to 4 years of prior mammogram images in addition to the most current mammogram, a 5-year AUROC of 0.78 (95% CI, 0.77-0.80) was obtained based on analysis of images alone. Performance was consistent across subgroups defined by race and ethnicity in East Asian (AUROC, 0.77; 95% CI, 0.75-0.79), Indigenous (AUROC, 0.77; 95% CI 0.71-0.83), and South Asian (AUROC, 0.75; 95% CI 0.71-0.79) women. Stratification by age gave a 5-year AUROC of 0.76 (95% CI, 0.74-0.78) for women aged 50 years or younger and 0.80 (95% CI, 0.78-0.82) for women older than 50 years. There were 18 839 participants (9.0%) with a 5-year risk greater than 3%, and the positive predictive value was 4.9% with an incidence of 11.8 per 1000 person-years.

CONCLUSIONS AND RELEVANCE

A dynamic MRS generated from both current and prior mammograms showed robust performance across diverse racial and ethnic populations in a province-wide screening program starting from age 40 years, reflecting improved accuracy for racially and ethnically diverse populations.

摘要

重要性

为使乳腺癌风险预测在临床上有用,它必须准确且适用于多种环境中的不同女性群体。

目的

检验一种结合既往乳房X光检查结果的动态风险预测模型,该模型先前已在黑人和白人女性中得到验证,能否在一项基于人群的筛查项目中,预测不同种族和族裔人群未来患乳腺癌的风险。

设计、设置和参与者:这项预后研究纳入了年龄在40至74岁之间、有1次或更多次筛查乳房X光检查的女性,这些检查数据来自2013年1月1日至2019年12月31日的不列颠哥伦比亚省乳房筛查项目,并通过与不列颠哥伦比亚癌症登记处的关联进行随访,直至2023年6月。这个省级有组织的筛查项目每2年提供一次采用全场数字化乳房X光摄影(FFDM)的筛查。数据于2024年5月至8月进行分析。

暴露因素

基于FFDM的、人工智能生成的乳房X光检查风险评分(MRS),包括长达4年的既往乳房X光检查结果。

主要结局和测量指标

主要结局是乳腺癌的5年风险(用受试者工作特征曲线下面积[AUROC]衡量)以及根据美国监测、流行病学和最终结果发病率校准的乳腺癌绝对风险。

结果

在206929名女性中(平均[标准差]年龄为56.1[9.7]岁;在118093名有种族数据的女性中,有34266名东亚女性、1946名原住民、6116名南亚女性和66742名白人女性),截至2023年6月,有4168例经病理确诊的新发乳腺癌。平均(标准差)随访时间为5.3(3.0)年。除了最新的乳房X光检查图像外,使用长达4年的既往乳房X光检查图像,仅基于图像分析得出的5年AUROC为0.78(95%置信区间,0.77 - 0.80)。在按种族和族裔定义的亚组中,东亚女性(AUROC为0.77;95%置信区间,0.75 - 0.79)、原住民女性(AUROC为0.77;95%置信区间0.71 - 0.83)和南亚女性(AUROC为0.75;95%置信区间0.71 - 0.79)的表现一致。按年龄分层,50岁及以下女性的5年AUROC为0.76(95%置信区间,0.74 - 0.78),50岁以上女性为0.80(95%置信区间,0.78 - 0.82)。有18839名参与者(9.0%)的5年风险大于3%,阳性预测值为4.9%,发病率为每1000人年11.8例。

结论和意义

由当前和既往乳房X光检查生成的动态MRS在一个全省范围的筛查项目中,从40岁开始,在不同种族和族裔人群中表现出强大的性能,这反映出对不同种族和族裔人群的准确性有所提高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb46/12144620/b20ab6243aff/jamanetwopen-e2512681-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb46/12144620/6c0d7f1716c8/jamanetwopen-e2512681-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb46/12144620/1036875e0a64/jamanetwopen-e2512681-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb46/12144620/b20ab6243aff/jamanetwopen-e2512681-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb46/12144620/6c0d7f1716c8/jamanetwopen-e2512681-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb46/12144620/1036875e0a64/jamanetwopen-e2512681-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb46/12144620/b20ab6243aff/jamanetwopen-e2512681-g003.jpg

相似文献

1
Validation of a Dynamic Risk Prediction Model Incorporating Prior Mammograms in a Diverse Population.在多样化人群中纳入既往乳腺钼靶检查结果的动态风险预测模型的验证
JAMA Netw Open. 2025 Jun 2;8(6):e2512681. doi: 10.1001/jamanetworkopen.2025.12681.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
Racial Differences in Screening Eligibility by Breast Density After State-Level Insurance Expansion.州级保险扩展后乳腺密度筛查资格的种族差异
JAMA Netw Open. 2025 Aug 1;8(8):e2525216. doi: 10.1001/jamanetworkopen.2025.25216.
5
The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.不同原发性乳腺癌治疗后监测性乳房 X 光造影方案的临床效果和成本效益:系统评价注册库分析和经济评估。
Health Technol Assess. 2011 Sep;15(34):v-vi, 1-322. doi: 10.3310/hta15340.
6
Artificial Intelligence Algorithm for Subclinical Breast Cancer Detection.人工智能算法用于早期乳腺癌检测。
JAMA Netw Open. 2024 Oct 1;7(10):e2437402. doi: 10.1001/jamanetworkopen.2024.37402.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Effectiveness and safety of vitamin D in relation to bone health.维生素D对骨骼健康的有效性与安全性。
Evid Rep Technol Assess (Full Rep). 2007 Aug(158):1-235.
9
Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.乳腺 X 线摄影联合乳腺超声与乳腺 X 线摄影用于一般风险女性乳腺癌筛查。
Cochrane Database Syst Rev. 2023 Mar 31;3(3):CD009632. doi: 10.1002/14651858.CD009632.pub3.
10
Development and Validation of Dynamic 5-Year Breast Cancer Risk Model Using Repeated Mammograms.使用重复乳房X光检查的动态5年乳腺癌风险模型的开发与验证
JCO Clin Cancer Inform. 2024 Dec;8:e2400200. doi: 10.1200/CCI-24-00200. Epub 2024 Dec 5.

本文引用的文献

1
External Testing of a Commercial AI Algorithm for Breast Cancer Detection at Screening Mammography.用于筛查乳腺钼靶摄影中乳腺癌检测的商用人工智能算法的外部测试
Radiol Artif Intell. 2025 May;7(3):e240287. doi: 10.1148/ryai.240287.
2
Development and Validation of Dynamic 5-Year Breast Cancer Risk Model Using Repeated Mammograms.使用重复乳房X光检查的动态5年乳腺癌风险模型的开发与验证
JCO Clin Cancer Inform. 2024 Dec;8:e2400200. doi: 10.1200/CCI-24-00200. Epub 2024 Dec 5.
3
Longitudinal history of mammographic breast density and breast cancer risk by familial risk, menopausal status, and initial mammographic density level in a high risk cohort: a nested case-control study.
基于家族风险、绝经状态和初始乳腺密度水平的高危队列中乳腺钼靶密度的纵向变化史与乳腺癌风险:一项巢式病例对照研究。
Breast Cancer Res. 2024 Nov 26;26(1):166. doi: 10.1186/s13058-024-01917-3.
4
Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement.乳腺癌筛查:美国预防服务工作组推荐声明。
JAMA. 2024 Jun 11;331(22):1918-1930. doi: 10.1001/jama.2024.5534.
5
Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.评估将多基因风险评分与非遗传因素相结合用于预测英国生物银行中乳腺癌诊断的价值。
Cancer Epidemiol Biomarkers Prev. 2024 Jun 3;33(6):812-820. doi: 10.1158/1055-9965.EPI-23-1432.
6
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
7
Artificial Intelligence-Driven Mammography-Based Future Breast Cancer Risk Prediction: A Systematic Review.基于人工智能驱动的乳腺钼靶摄影的未来乳腺癌风险预测:一项系统综述。
J Am Coll Radiol. 2024 Feb;21(2):319-328. doi: 10.1016/j.jacr.2023.10.018. Epub 2023 Nov 8.
8
Repeated measures of mammographic density and texture to evaluate prediction and risk of breast cancer: a systematic review of the methods used in the literature.反复测量乳腺密度和纹理以评估乳腺癌的预测和风险:文献中使用方法的系统评价。
Cancer Causes Control. 2023 Nov;34(11):939-948. doi: 10.1007/s10552-023-01739-2. Epub 2023 Jun 20.
9
Comparison of Mammography AI Algorithms with a Clinical Risk Model for 5-year Breast Cancer Risk Prediction: An Observational Study.对比钼靶 X 线摄影人工智能算法与临床风险模型预测 5 年乳腺癌风险:一项观察性研究。
Radiology. 2023 Jun;307(5):e222733. doi: 10.1148/radiol.222733.
10
Longitudinal Analysis of Change in Mammographic Density in Each Breast and Its Association With Breast Cancer Risk.每个乳房的乳腺密度变化的纵向分析及其与乳腺癌风险的关系。
JAMA Oncol. 2023 Jun 1;9(6):808-814. doi: 10.1001/jamaoncol.2023.0434.